Olon Spa

Activities: Ingredients

Trending Articles

  1. Enhancing solubility with novel excipients With the growing prevalence of complex drug molecules, formulation is becoming ever more challenging. Novel excipients can unlock their potential, says Meera Raghuram, Director...
  2. SGS achieves breakthrough in infectious disease research with launch of novel RSV A-strain Derived from a 2015 circulating strain, SGS's novel RSV-A challenge agent offers a closer match to circulating RSV viruses than strains currently used in clinical research
  3. Poolbeg Pharma trial to feature in groundbreaking cancer immunotherapy-induced CRS research programme Poolbeg will act as the lead business partner, alongside Johnson & Johnson and other partners, on the University of Manchester and The Christie NHS Foundation Trust research...
  4. Buckland Group launches Quvara Medical after acquiring Becton Dickinson’s Swindon site to boost UK-EU medical manufacturing The acquisition establishes Quvara Medical as a new UK- and EU-based CMO offering GMP- and ISO-certified, high-volume manufacturing services to pharma and medtech clients
  5. SeaBeLife partners with Unither Pharmaceuticals for ophthalmic drug production The new partnership aims to produce clinical and commercial batches of ophthalmic formulation of SeaBeLife’s drug candidate SBL03 to treat degenerative disorders of the...

Upcoming event

From powder to granules: a deep dive into wet granulation methods

14 January 2026 | Virtual See all

Related Content

Marketing

Olon highlights integrated expertise and innovation at CPHI Frankfurt 2025

Following this year’s CPhI Frankfurt, Olon highlighted its integrated expertise and innovative solutions that are shaping the life sciences industry
Sustainability

Olon releases its annual ESG report

The Italian Group, leading international API supplier, presents the 2023 sustainability report and confirms the sustainability journey toward energy transition, investments in alternative energy sources, social and economic involvement and support for the communities in which it operates
Manufacturing

Manufacturing Chemist Stand Side with Olon Spa

We discover what exhibitors at CPHI Milan 2024 are showcasing LIVE!
Manufacturing

Olon commits to ultra-potent compound manufacturing expansion with new €25m facility

The CDMO's integrated small and large-scale lines can produce payloads, linker payloads and ultra-potent APIs for customers across Europe
Manufacturing

Olon strengthens market position with acquisitions ahead of CPHI Milan

Two new acquisitions expand Olon’s service offerings and production capacity
Manufacturing

Olon publishes white paper on managing nitrosamine standards

Company's rapid response to FDA, EMA, and Health Canada regulations highlighted in new publication
Ingredients

Olon continues its growth with a new acquisition

The acquisition of Huvepharma Italia Srl increases production capacity and expands market presence
Subscribe now